Bristol-Myers, Natco And More Can't Ditch Cancer Drug MDL
A New Jersey federal judge Tuesday refused to throw out sprawling antitrust multidistrict litigation over Celgene Corp.'s cancer drug Revlimid filed against Bristol-Myers Squibb, Natco Pharma, AbbVie and other pharmaceutical companies,...To view the full article, register now.
Already a subscriber? Click here to view full article